Skip to main content
Start triage

Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Need urgent help? Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Roxee Meds Catalog

Clavulanate Potassium

Medication catalog facts with explicit FDA-approval, off-label, source-limited, and safety context.

Both Source review pending Regulatory linkage incomplete Owner quick guide first
Start Symptom Intake Talk to a Vet / Find a Vet Near You

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Data freshness

Storefront facts
Source review pending
No refresh timestamp yet

Roxee is still reviewing source support for this medication profile.

FDA applications
Regulatory match pending
No refresh timestamp yet

Roxee has safety or ingredient evidence for this medication, but a regulatory product/application match is still pending.

Safety reports
No safety reports linked
No refresh timestamp yet

openFDA reaction terms and case summaries are supporting evidence, not proof of causality.

Source timing details
Source timing details
  • Storefront facts: Source Roxee | Refreshed May 2, 2026, 10:05 AM UTC
    The storefront fact projection used for browse cards and quick facts.

Evidence

Reviewed / Updated / Sources

Reviewed by: Not available

Last reviewed: May 2, 2026

Updated: May 2, 2026, 10:05 AM UTC

Sources:
Image coming soon
Clavulanate Potassium

Clavulanate Potassium

Drug type: Generic ingredient • Generic profile • Regulatory linkage incomplete

Both 76% storefront ready

Species: Both

Approval status: Official document linked, regulatory match incomplete. An official source document is available, but Roxee has not linked this row to a confirmed FDA animal-drug application or product record yet.

Medication Snapshot

Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.

Clavulanate Potassium

Clavamox Drops are indicated in the treatment of skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma due to susceptible strains of the following organisms: ß-lactamase-producing Staphylo coccus aureus , non- ß -lactamase-producing Staphylococcus aureus , Staphylococcus spp., Streptococcus spp., and E. coli . Periodontal infections due to susceptible strains of both aerobic and anaerobic bacteria. Clavamox has been shown to be clinically effective for treating cases of canine periodontal disease. Clavamox Drops are indicated in the treatment of skin and soft tissue infections such as wounds, abscesses, and cellulitis/dermatitis due to susceptible strains of the following organisms: ß-lactamase-producing Staphylococcus aureus , non-ß-lactamase-producing Staphylococcus aureus , Staphylococcus spp., Streptococcus spp., E. coli , Pasteurella multocida , and Pasteurella spp. Urinary tract infections (cystitis) due to susceptible strains of E. coli . Therapy may be initiated with Clavamox prior to obtaining results from bacteriological and susceptibility studies. A culture should be obtained prior to treatment to determine susceptibility of the organisms to Clavamox. Following determination of susceptibility results and clinical response to medication, therapy may be reevaluated. For the treatment of skin and soft tissue infections such as wounds, abscesses, and cellulitis/dermatitis due to susceptible strains of the following organisms: ß-lactamase-producing Staphylococcus aureus, non-ß-lactamase-producing Staphylococcus aureus, Staphylococcus spp., Streptococcus spp., E. coli, and Pasteurella spp. Urinary tract infections (cystitis) due to susceptible strains of E. coli. Species commonly shown: Both.

Generic name
Clavulanate Potassium
Species
Both
Completeness
76%
Validation
Incomplete

Indications / Uses

Clavamox Drops are indicated in the treatment of skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma due to susceptible strains of the following organisms: ß-lactamase-producing Staphylo coccus aureus , non- ß -lactamase-producing Staphylococcus aureus , Staphylococcus spp., Streptococcus spp., and E. coli . Periodontal infections due to susceptible strains of both aerobic and anaerobic bacteria. Clavamox has been shown to be clinically effective for treating cases of canine periodontal disease. Clavamox Drops are indicated in the treatment of skin and soft tissue infections such as wounds, abscesses, and cellulitis/dermatitis due to susceptible strains of the following organisms: ß-lactamase-producing Staphylococcus aureus , non-ß-lactamase-producing Staphylococcus aureus , Staphylococcus spp., Streptococcus spp., E. coli , Pasteurella multocida , and Pasteurella spp. Urinary tract infections (cystitis) due to susceptible strains of E. coli . Therapy may be initiated with Clavamox prior to obtaining results from bacteriological and susceptibility studies. A culture should be obtained prior to treatment to determine susceptibility of the organisms to Clavamox. Following determination of susceptibility results and clinical response to medication, therapy may be reevaluated. For the treatment of skin and soft tissue infections such as wounds, abscesses, and cellulitis/dermatitis due to susceptible strains of the following organisms: ß-lactamase-producing Staphylococcus aureus, non-ß-lactamase-producing Staphylococcus aureus, Staphylococcus spp., Streptococcus spp., E. coli, and Pasteurella spp. Urinary tract infections (cystitis) due to susceptible strains of E. coli.

Warnings / Contraindications

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

  • Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Side Effects

Top reported reactions (openFDA): Elevated alanine aminotransferase (ALT), Brain disorder NOS, Bruising, Circling - neurological disorder (see also Behavioural disorders), Distension of abdomen, Ecchymosis.

FAQ

Both

Related Conditions

Abscesses (cat bite abscess) Periodontal Disease (Dental Disease) Periodontal Disease (Gingivitis/Periodontitis) Pyoderma (superficial/deep) Urinary tract infection (cystitis)

Add to My Pet's Meds

Choose a pet, confirm current or past, and optionally add reminder notes.

Sign in to save this medication to your pet profile.

Sign in to continue

Pet Owner Quick Guide

Start here first for the safest next-step summary before the deeper medication detail.

Used for:

Clavamox Drops are indicated in the treatment of skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma due to susceptible strains of the following organisms: ß-lact...

Dosing note:

Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.

What to watch for:

  • wobbly/unsteady walking (1 reports)
  • Pain NOS (1 reports)
  • Pacing (1 reports)

When to call the vet:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
  • Facial swelling or hives.
  • Blood in vomit or stool.

Regulatory restrictions are shown in Vet View.

What to tell or ask your vet today:

  • Is this medicine the right fit for my pet’s current symptoms?
  • Which warning signs mean I should call back right away?
  • How should I handle missed doses or refusal to take the medicine?
Major cautions & emergency warning signs

Side effects to monitor:

  • wobbly/unsteady walking
  • Pain NOS
  • Pacing

Most reported reactions:

  • Unsteady walking (ataxia) (1 reports)
  • Pain NOS (1 reports)
  • Pacing (1 reports)

Emergency warning signs:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
Talk to a Vet / Find a Vet Near You Start Symptom Intake

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both
Manufacturer: Manufacturer not confirmed
Identifiers:
ANADA: 200592 ANADA: 200604 ANADA: 200702 ANADA: 200709 NADA: 55101 NDC Package: 11695-6991-1 NDC Package: 11695-6992-1 NDC Package: 11695-6993-1 NDC Package: 11695-6994-1 NDC Package: 11695-7007-1 NDC Package: 13744-540-01 NDC Package: 13744-541-01 NDC Package: 13744-542-01 NDC Package: 13744-543-01 NDC Package: 17033-440-07 NDC Package: 17033-440-21 NDC Package: 17033-441-07 NDC Package: 17033-441-21 NDC Package: 17033-442-07 NDC Package: 17033-442-21

Warnings / Contraindications

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

  • High: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Source metadata:

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Tap or hover a reaction to see what it means in plain language.

Tracked signals
32
Reported cases
32
Serious reports
26
Species represented
2
Grouped by Body System
Digestive (1) · Diarrhea Neurologic (2) · Unsteady walking (ataxia), Circling - neurological disorder Other (29) · Pain NOS, Pacing, Onset of lactation
Most Reported Reactions
Reaction Body system Cases Species Serious cases
Neurologic 1 Cat 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Cat 1
Other 1 Dog 1
Other 1 Dog 1

Species coverage: Dog (22) Cat (10)

View detailed reaction table
Reaction Body system Species Seriousness Frequency Reports
Neurologic Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Non-serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Cat Non-serious - 1
Other Cat Non-serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Digestive Cat Non-serious - 1
Other Cat Non-serious - 1
Neurologic Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Non-serious - 1
Source metadata:

Documents

Owner handouts and official technical documents open on-page first, with the original source still one click away.

Only technical FDA review documents are linked right now. Owner handouts, official label / PI, and SPL documents are not linked yet.

Owner handouts

0
No owner handouts linked yet.

Official label / PI

0
No official label or package insert links yet.

SPL

0
No SPL links yet.

FOI

5

FOI Summary oA 200-709 Approved August 18, 2021.pdf

FOI · FOI summary

Open original

FOI Summary oA 200-702 Approved April 23, 2021.pdf

FOI · FOI summary

Open original

N055101_Supp_12_23_1997.pdf

FOI · FOI summary

Open original

FOI Summary oA 200-604 Approved October 20, 2021.pdf

FOI · FOI summary

Open original

UCM524262.pdf

FOI · FOI summary

Open original
Source metadata:
Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness
  • Storefront facts: Source Roxee | Refreshed May 2, 2026, 10:05 AM UTC
    The storefront fact projection used for browse cards and quick facts.
Official (FDA)
Identity: Generic ingredient • No FDA branded products linked
No official FDA brand rows linked yet for this ingredient.
Catalog species: Both
Safety (openFDA)
Top reactions: Dog 0 • Cat 0 • View
Case summaries: 0
openFDA reports are unverified and do not prove causation.
Explore
Linked using: Usage_Inferred (0.78), Usage_Inferred (0.78), Usage_Inferred (0.78)
Diagnosis Codes
ICD10_CM: K05.6
Periodontal disease, unspecified

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Owner-facing counseling points
  • Federal law restricts this drug to use by or on the order of a licensed veterinarian. (Contraindication, High)
Top reaction signals
Unsteady walking (ataxia) (1) Pain NOS (1) Pacing (1) Onset of lactation (1) Not sleeping (1) Not eating (1) Neoplasia NOS (1) Meningitis (1)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers
ANADA: 200592 ANADA: 200604 ANADA: 200702 ANADA: 200709 NADA: 55101 NDC Package: 11695-6991-1 NDC Package: 11695-6992-1 NDC Package: 11695-6993-1 NDC Package: 11695-6994-1 NDC Package: 11695-7007-1 NDC Package: 13744-540-01 NDC Package: 13744-541-01 NDC Package: 13744-542-01 NDC Package: 13744-543-01 NDC Package: 17033-440-07 NDC Package: 17033-440-21 NDC Package: 17033-441-07 NDC Package: 17033-441-21 NDC Package: 17033-442-07 NDC Package: 17033-442-21 NDC Package: 17033-443-07 NDC Package: 17033-443-21 NDC Package: 17033-451-15 NDC Package: 46066-087-17
Package NDC Product NDC Form / Route Status
11695-6991-1 11695 -
11695-6992-1 11695 -
11695-6993-1 11695 -
11695-6994-1 11695 -
11695-7007-1 11695 -
13744-540-01 13744 -
13744-541-01 13744 -
13744-542-01 13744 -
13744-543-01 13744 -
17033-440-07 17033 -
17033-440-21 17033 -
17033-441-07 17033 -
17033-441-21 17033 -
17033-442-07 17033 -
17033-442-21 17033 -
17033-443-07 17033 -
17033-443-21 17033 -
17033-451-15 17033 -
46066-087-17 46066 -
46066-111-60 46066 -

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 11 Clinical 9 Manufacturer 0 Marketing 0
Current Field Facts
  • contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. (Clinical, 2026-05-02)
  • contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. (Clinical, 2026-04-15)
  • contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. (Clinical, 2026-04-11)
  • side_effects: Top reported reactions (openFDA): Elevated alanine aminotransferase (ALT), Brain disorder NOS, Bruising, Circling - neurological disorder (see also Behavioural… (Clinical, 2026-05-02)
  • side_effects: Top reported reactions (openFDA): Elevated alanine aminotransferase (ALT), Brain disorder NOS, Bruising, Circling - neurological disorder (see also Behavioural… (Clinical, 2026-04-15)
  • side_effects: Top reported reactions (openFDA): Elevated alanine aminotransferase (ALT), Brain disorder NOS, Bruising, Circling - neurological disorder (see also Behavioural… (Clinical, 2026-04-11)
  • usage: Clavamox Drops are indicated in the treatment of skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma … (Clinical, 2026-05-02)
  • usage: Clavamox Drops are indicated in the treatment of skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma … (Clinical, 2026-04-15)
  • usage: Clavamox Drops are indicated in the treatment of skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma … (Clinical, 2026-04-11)
  • contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. (Official, 2026-04-30)
  • contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. (Official, 2026-02-12)
  • side_effects: Top reported reactions (openFDA): Elevated alanine aminotransferase (ALT), Brain disorder NOS, Bruising, Circling - neurological disorder (see also Behavioural… (Official, 2026-04-30)
  • side_effects: Top reported reactions (openFDA): Elevated alanine aminotransferase (ALT), Brain disorder NOS, Bruising, Circling - neurological disorder (see also Behavioural… (Official, 2026-02-12)
  • usage: Clavamox Drops are indicated in the treatment of skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma … (Official, 2026-04-30)
  • usage: Clavamox Drops are indicated in the treatment of skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma … (Official, 2026-02-12)
Recent Revisions
  • side_effects updated 2026-05-02 10:05 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-05-02 10:05 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-05-02 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-30 10:09 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-30 10:09 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-30 10:09 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-15 10:04 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-15 10:04 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-15 10:04 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields

Usage

Clavamox Drops are indicated in the treatment of skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma due to susceptible strains of the following organisms: ß-lactamase-producing Staphylo coccus aureus , non- ß -lactamase-producing Staphylococcus aureus , Staphylococcus spp., Streptococcus spp., and E. coli . Periodontal infections due to susceptible strains of both aerobic and anaerobic bacteria. Clavamox has been shown to be clinically effective for treating cases of canine periodontal disease. Clavamox Drops are indicated in the treatment of skin and soft tissue infections such as wounds, abscesses, and cellulitis/dermatitis due to susceptible strains of the following organisms: ß-lactamase-producing Staphylococcus aureus , non-ß-lactamase-producing Staphylococcus aureus , Staphylococcus spp., Streptococcus spp., E. coli , Pasteurella multocida , and Pasteurella spp. Urinary tract infections (cystitis) due to susceptible strains of E. coli . Therapy may be initiated with Clavamox prior to obtaining results from bacteriological and susceptibility studies. A culture should be obtained prior to treatment to determine susceptibility of the organisms to Clavamox. Following determination of susceptibility results and clinical response to medication, therapy may be reevaluated. For the treatment of skin and soft tissue infections such as wounds, abscesses, and cellulitis/dermatitis due to susceptible strains of the following organisms: ß-lactamase-producing Staphylococcus aureus, non-ß-lactamase-producing Staphylococcus aureus, Staphylococcus spp., Streptococcus spp., E. coli, and Pasteurella spp. Urinary tract infections (cystitis) due to susceptible strains of E. coli.

Contraindications

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Digestive
Diarrhea (1) • Cat

Showing top 5 for Digestive.

Neurologic
Unsteady walking (1) • Cat Circling - neurological disorder (1) • Dog

Showing top 5 for Neurologic.

Other
Pain NOS (1) • Dog Pacing (1) • Dog Onset of lactation (1) • Dog Odor, Abnormal (1) • Cat Not sleeping (1) • Dog
Show more (24)
Not eating (1) • Cat Neoplasia NOS (1) • Dog Meningitis (1) • Dog Lymphopenia (1) • Dog Leucocytosis NOS (1) • Dog Less social (1) • Dog Large platelets (1) • Dog Hypoglycaemia (1) • Dog Head shake - ear disorder (1) • Cat Head bobbing (1) • Dog Gait abnormality (1) • Cat Foaming at the mouth (1) • Dog Eye redness (1) • Cat Eye irritation (1) • Cat Elevated serum alkaline phosphatase (1) • Dog Elevated cholesterol (1) • Dog Elevated blood urea nitrogen (1) • Dog Elevated alanine aminotransferase (1) • Dog Ecchymosis (1) • Dog Distension of abdomen (1) • Dog Color, Abnormal (1) • Cat Bruising (1) • Dog Brain disorder NOS (1) • Dog Accidental exposure (1) • Cat

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

No case-level openFDA reports are linked for this medication yet.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

This medication has not been reviewed by a veterinarian yet.